This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34587751
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ vědecký článek artigo científico (publicado na 2008) מאמר מדעי vetenskaplig artikel научна статия teaduslik artikkel 2008年論文 2008年論文 artykuł naukowy article científic artikull shkencor 2008年论文 wetenschappelijk artikel мақолаи илмӣ naučni članak 2008年论文 articolo scientifico mokslinis straipsnis artículo científico publicado en 2008 artigo científico vitskapeleg artikkel 2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած مقالهٔ علمی 2008年論文 2008 թվականի փետրվարին հրատարակված գիտական հոդված article scientifique (publié 2008) artículu científicu espublizáu en 2008 artigo científico (publicado na 2008) سائنسی مضمون vedecký článok tieteellinen artikkeli 2008年の論文 სამეცნიერო სტატია 2008年论文 2008年论文 научни чланак tudományos cikk vitenskapelig artikkel مقالة علمية ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ наукова стаття, опублікована в лютому 2008 2008년 논문 bài báo khoa học 2008年論文 научная статья 2008年論文 2008 nî lūn-bûn научни чланак wissenschaftlicher Artikel artikulong pang-agham επιστημονικό άρθρο 2008年论文 bilimsel makale article scientific 2008年论文 articol științific scienca artikolo scientific article บทความทางวิทยาศาสตร์ videnskabelig artikel (udgivet 2008)
p:P577
wds:Q34587751-19E6863F-D28C-4BC3-A789-F8BDDB9CF3D0
wdt:P577
2008-02-01T00:00:00Z
p:P407
wds:Q34587751-B9B939AD-93A7-40FE-B4A3-48FF7E64C7E7
wdt:P407
wd:Q1860
p:P2093
wds:Q34587751-AAB10C83-B9D1-4255-897B-34F49B3C1CAA wds:Q34587751-7A82C2B5-E63B-4207-A071-D21C0CA0ED4F wds:Q34587751-853DC543-D66F-40F6-A0E9-FC0F2E5E319E wds:Q34587751-5EE66504-A251-4F79-AD2B-2EC81A86EDF6 wds:Q34587751-75241B9C-7877-4FD7-B487-73CF0889B55E wds:Q34587751-45C86130-2CE1-4E0E-BFB6-A2220490E9E5 wds:Q34587751-1A12018B-17E4-4097-AA2C-800E70743D69 wds:Q34587751-F9618AB6-A79E-4B85-A392-444CE4E96687 wds:Q34587751-F1C536EE-EE3D-4280-8F4F-168BD2225507 wds:Q34587751-F3713777-BD6C-45D6-88C6-2E6A85C87C2B wds:Q34587751-F07B5B85-EE67-44EC-B8D5-65F3319F1CB8 wds:Q34587751-1794F711-FE34-4BAD-A819-FF4B8A997353 wds:Q34587751-00791AC8-6ECD-410F-9F0C-5F3EB0838C53 wds:Q34587751-0826C54E-EF3C-4D50-B596-5E0A1863AF27
wdt:P2093
Charles D Blanke J Randolph Hecht Robert S Benjamin George D Demetri Laurence H Baker Vivien H C Bramwell Ernest C Borden A Kevin Raymond Christopher W Ryan Cathryn Rankin John J Crowley Michael Tanaka Margaret von Mehren Christopher D M Fletcher
rdfs:label
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
skos:prefLabel
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
schema:name
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
p:P50
wds:Q34587751-394F0FAC-C233-46B4-B48C-9F2FCAD166F5 wds:Q34587751-BB6C7F6F-47A8-44C6-8D3E-80E239722C31
wdt:P50
wd:Q40526741 wd:Q47451450
p:P1476
wds:Q34587751-11D2EA64-8342-4CB3-B2CC-96DF8819F1B6
wdt:P1476
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
p:P304
wds:Q34587751-003A1337-467C-4849-B220-B605F896DBB1
wdt:P304
626-632
p:P31
wds:Q34587751-35B73FCB-9ED0-4E7D-9163-2D614C30566E
wdt:P31
wd:Q13442814
p:P921
wds:Q34587751-97C18CCF-35C6-4B74-916B-1C313FDCEC4A wds:Q34587751-127A6722-1269-4202-A651-DF9E8E4E7CCD wds:Q34587751-BDBD79B2-FAA5-43A5-8132-9C94BB5516EF
wdt:P921
wd:Q177094 wd:Q42824827 wd:Q181600
p:P698
wds:Q34587751-1E838049-43FE-40F3-BF3A-238E39865944
wdtn:P698
n10:18235122
wdt:P698
18235122
p:P1433
wds:Q34587751-31C27C0B-9987-46BF-9D8D-A0E426CFF122
wdt:P1433
wd:Q400292
p:P433
wds:Q34587751-20A4A464-7972-4F5D-8982-09CA8A84C444
p:P478
wds:Q34587751-E306899D-8AB7-4FEF-B353-67604C030008
wdt:P433
4
wdt:P478
26
p:P356
wds:Q34587751-4555586D-3AEB-4E01-A2FC-9BE820180B52
wdtn:P356
n11:JCO.2007.13.4452
wdt:P356
10.1200/JCO.2007.13.4452
p:P8608
wds:Q34587751-D04D5185-3D5E-442A-8893-E8ECFBC7B72F
wdt:P8608
release_5ylugx3ghveypfntkr24uvqd3m